Japan Health Insurance to Cover Expensive Leukemia Drug
Newsfrom JapanPolitics Lifestyle
Tokyo, May 15 (Jiji Press)--A Japanese government panel on Wednesday approved a health ministry proposal that an expensive new drug for intractable leukemia and lymphoma be covered by the national health insurance system.
Kymriah will join the list of drugs covered by the system May 22, with its domestic sales price set at 33,493,407 yen, the most expensive drug on the list.
How much the Japanese price would be had drawn attention. In the United States, the price of the drug stands at about 50 million yen.
The approval was given by the Central Social Insurance Medical Council, which advises the health minister.
Kymriah, developed by Swiss drug maker Novartis AG, is used in chimeric antigen receptor (CAR) T-cell therapy, which employs genetically modified immune cells of patients.
[Copyright The Jiji Press, Ltd.]